NCT00387946 Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN) Status COMPLETED Phase PHASE3
NCT00387907 Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00386685 XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00386503 Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions Status COMPLETED Phase PHASE1
NCT00386191 Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment Status COMPLETED Phase PHASE4
NCT00385411 Study of Valproate in Young Patients Suffering From Epilepsy Status COMPLETED Phase PHASE4
NCT00385307 Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS) Status COMPLETED Phase PHASE3
NCT00384215 Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin Status COMPLETED Phase PHASE4
NCT00383734 Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE Status COMPLETED Phase PHASE3
NCT00381706 Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00380991 Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene Status COMPLETED Phase PHASE3
NCT00380302 Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. Status COMPLETED Phase PHASE1/PHASE2
NCT00379717 Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase PHASE1/PHASE2
NCT00378573 Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00377780 Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2